Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Space Exploration Techn CorpCL A | 1,398,815 | 923,218 | -475,597 | $239.00M | $139.28M | 25.50% | -$99.72M |
| Aktis Oncology, Inc.(AKTS) | 3,070,219 | 3,343,827 | +273,608 | $98.95M | $65.10M | 11.92% | -$33.85M |
| Latigo Biotherapeutics Inc | 0 | 3,596,780 | +3,596,780 | $0 | $60.07M | 11.00% | +$60.07M |
| Larimar Therapeutics Inc | 9,163,157 | 9,923,904 | +760,747 | $27.95M | $31.71M | 5.81% | +$3.76M |
| Electra Therapeutics Inc | 0 | 2,611,143 | +2,611,143 | $0 | $29.38M | 5.38% | +$29.38M |
| Nuveen Churchill Direct Lend | 2,143,626 | 2,143,626 | 0 | $26.62M | $24.09M | 4.41% | -$2.53M |
| Cullinan Therapeutics Inc | 1,539,764 | 1,399,899 | -139,865 | $28.04M | $21.49M | 3.93% | -$6.55M |
| Blue Owl Capital Corporation(OBDC) | 2,045,070 | 2,045,070 | 0 | $22.23M | $21.45M | 3.93% | -$777.1K |
| Obsidian Therapeutics Inc | 0 | 1,482,767 | +1,482,767 | $0 | $20.36M | 3.73% | +$20.36M |
| Sagimet Biosciences IncCOM SER A | 1,260,544 | 1,125,544 | -135,000 | $9.74M | $11.12M | 2.04% | +$1.38M |
| Dell Technologies Inc.CL C(DELL) | 32,961 | 19,342 | -13,619 | $14.22M | $10.41M | 1.91% | -$3.82M |
| Holley Inc | 4,376,888 | 4,376,888 | 0 | $11.16M | $10.33M | 1.89% | -$831.6K |
| Conduent Inc | 5,036,595 | 5,036,595 | 0 | $7.35M | $7.86M | 1.44% | +$503.7K |
| Deep Fission Inc | 1,333,333 | 1,333,333 | 0 | $14.72M | $6.84M | 1.25% | -$7.88M |
| Aquestive Therapeutics Inc | 942,932 | 1,390,632 | +447,700 | $3.92M | $6.44M | 1.18% | +$2.52M |
| Immix Biopharma Inc | 437,552 | 602,047 | +164,495 | $4.51M | $6.26M | 1.15% | +$1.75M |
| Maplight Therapeutics Inc | 729,929 | 556,371 | -173,558 | $26.16M | $5.67M | 1.04% | -$20.49M |
| Veradermics, Incorporated(MANE) | 0 | 45,000 | +45,000 | $0 | $5.46M | 1.00% | +$5.46M |
| Imagenebio Inc | 917,692 | 1,135,081 | +217,389 | $5.41M | $5.20M | 0.95% | -$215.7K |
| Opus Genetics Inc | 0 | 969,605 | +969,605 | $0 | $4.69M | 0.86% | +$4.69M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 608,600 | 358,600 | -250,000 | $9.09M | $4.13M | 0.76% | -$4.96M |
| Rezolute Inc | 0 | 935,000 | +935,000 | $0 | $3.87M | 0.71% | +$3.87M |
| Artiva Biotherapeutics Inc | 874,542 | 529,542 | -345,000 | $8.48M | $3.77M | 0.69% | -$4.71M |
| Cybin Inc | 59,911 | 288,282 | +228,371 | $396.0K | $3.54M | 0.65% | +$3.15M |
| Achieve Life Science Inc | 0 | 412,654 | +412,654 | $0 | $3.34M | 0.61% | +$3.34M |
| Procore Technologies, Inc.(PCOR) | 0 | 64,030 | +64,030 | $0 | $3.31M | 0.61% | +$3.31M |
| Compass Therapeutics Inc | 3,624,076 | 3,154,076 | -470,000 | $7.94M | $3.28M | 0.60% | -$4.66M |
| Palvella Therapeutics, Inc.(PVLA) | 36,259 | 23,003 | -13,256 | $5.54M | $3.17M | 0.58% | -$2.37M |
| Zura Bio LtdCL A | 0 | 735,000 | +735,000 | $0 | $3.06M | 0.56% | +$3.06M |
| Lenz Therapeutics Inc | 756,722 | 781,722 | +25,000 | $4.30M | $3.00M | 0.55% | -$1.30M |
| Starwood Property Trust, Inc.(STWD) | 196,355 | 196,355 | 0 | $3.22M | $2.65M | 0.49% | -$565.5K |
| Pyxis Oncology Inc | 0 | 1,000,000 | +1,000,000 | $0 | $2.33M | 0.43% | +$2.33M |
| Viridian Therapeutics, Inc.(VRDN) | 260,000 | 100,000 | -160,000 | $4.78M | $2.06M | 0.38% | -$2.72M |
| Netskope, Inc.CL A(NTSK) | 0 | 97,148 | +97,148 | $0 | $1.69M | 0.31% | +$1.69M |
| ServiceTitan, Inc.CL A(TTAN) | 0 | 25,360 | +25,360 | $0 | $1.67M | 0.31% | +$1.67M |
| First Advantage Corporation(FA) | 0 | 88,665 | +88,665 | $0 | $1.58M | 0.29% | +$1.58M |
| Eledon Pharmaceuticals Inc | 566,509 | 566,509 | 0 | $2.23M | $1.43M | 0.26% | -$798.8K |
| Ww Intl Inc | 84,399 | 71,277 | -13,122 | $1.35M | $1.10M | 0.20% | -$246.8K |
| Adc Therapeutics SaSHS | 733,568 | 733,568 | 0 | $784.9K | $895.0K | 0.16% | +$110.0K |
| Stablecoinx IncW EXP 06 25 203 | 250,000 | 167,795 | -82,205 | $102.5K | $839.0K | 0.15% | +$736.5K |
| Marker Therapeutics Inc | 554,250 | 554,250 | 0 | $814.7K | $593.0K | 0.11% | -$221.7K |
| Fold Hldgs IncCL A | 856,632 | 856,632 | 0 | $385.5K | $454.0K | 0.08% | +$68.5K |
| Niocorp Devs LtdW EXP 03 17 202 | 268,280 | 268,280 | 0 | $381.0K | $201.2K | 0.04% | -$179.7K |
| Piper Sandler Companies(PIPR) | 2,428 | 2,428 | 0 | $175.6K | $160.2K | 0.03% | -$15.5K |
| Caris Life Sciences, Inc.(CAI) | 4,711 | 4,711 | 0 | $84.0K | $144.3K | 0.03% | +$60.3K |
| Rezolve Ai PlcW EXP 08 15 202 | 235,121 | 235,121 | 0 | $214.0K | $129.3K | 0.02% | -$84.6K |
| Energy Transfer LPCOM UT LTD PTN(ET) | 5,326 | 5,326 | 0 | $101.8K | $105.3K | 0.02% | +$3.5K |
| Engene Therapeutics IncW EXP 10 31 202 | 511,177 | 511,177 | 0 | $148.2K | $102.3K | 0.02% | -$45.9K |
| Vodafone Group Public Limited CompanyADR(VOD) | 5,371 | 5,371 | 0 | $71.0K | $86.8K | 0.02% | +$15.8K |
| Brand Engagement Network IncW EXP 03 14 202 | 1,453,808 | 746,953 | -706,855 | $203.5K | $37.3K | 0.01% | -$166.2K |
| Alpha Modus Hldgs IncW EXP 12 13 202 | 1,854,665 | 1,854,665 | 0 | $55.6K | $37.1K | 0.01% | -$18.5K |
| Tactical Res Corp | 0 | 11,250 | +11,250 | $0 | $29.9K | 0.01% | +$29.9K |
| Monte Rosa Therapeutics Inc | 0 | 2,392 | +2,392 | $0 | $28.5K | 0.01% | +$28.5K |
| Dave Inc.W EXP 01 05 202(DAVE) | 28,750 | 28,750 | 0 | $68.4K | $28.2K | 0.01% | -$40.3K |
| Roadzen IncW EXP 11 30 202 | 225,000 | 225,000 | 0 | $42.8K | $22.5K | 0.00% | -$20.3K |
| Southland Hldgs IncW EXP 02 14 202 | 860,302 | 860,302 | 0 | $25.8K | $17.2K | 0.00% | -$8.6K |
| Livewire Group IncW EXP 09 26 202 | 400,000 | 400,000 | 0 | $8.0K | $16.0K | 0.00% | +$8.0K |
| Alpha Modus Hldgs IncCL A | 9,853 | 9,853 | 0 | $42.0K | $15.3K | 0.00% | -$26.7K |
| Aeon Biopharma IncCL A | 42,353 | 42,353 | 0 | $30.5K | $12.7K | 0.00% | -$17.8K |
| Tevogen IncW EXP 02 14 202 | 200,000 | 200,000 | 0 | $12.0K | $12.0K | 0.00% | $0 |
| Shf Holdings IncCL A | 0 | 6,324 | +6,324 | $0 | $9.3K | 0.00% | +$9.3K |
| Blue Gold LtdW EXP 04 01 203 | 175,000 | 175,000 | 0 | $21.0K | $7.0K | 0.00% | -$14.0K |
| Zeo Energy CorpW EXP 03 13 202 | 250,000 | 250,000 | 0 | $10.0K | $5.0K | 0.00% | -$5.0K |
| Nvni Group LimitedW EXP 11 01 202 *W EXP 11/01/202 | 200,000 | 200,000 | 0 | $6.0K | $4.0K | 0.00% | -$2.0K |
| Katapult Holdings Inc | 5,421 | 5,421 | 0 | $5.4K | $3.5K | 0.00% | -$1.8K |
| Baird Med Invt Hldgs LtdW EXP 10 01 202 *W EXP 10/01/202 | 100,000 | 100,000 | 0 | $4.0K | $3.0K | 0.00% | -$1.0K |
| Liminatus Pharma IncW EXP 04 30 203 | 50,000 | 50,000 | 0 | $2.0K | $2.0K | 0.00% | $0 |
| Xbp Global Holdings IncW EXP 11 30 202 | 24,778 | 24,778 | 0 | $1.5K | $1.2K | 0.00% | -$248 |
| Stardust Pwr IncW EXP 06 21 202 | 16,666 | 16,666 | 0 | $2.2K | $1.2K | 0.00% | -$1.0K |
| Aspire-Lakewood Holdings IncW EXP 02 18 203 | 50,000 | 50,000 | 0 | $1.0K | $500 | 0.00% | -$500 |
| Pagaya Technologies Ltd.W EXP 99 99 999(PGY) | 48,661 | 48,661 | 0 | $2.4K | $487 | 0.00% | -$1.9K |
| Waldencast PlcW EXP 07 27 202 | 33,333 | 33,333 | 0 | $1.7K | $333 | 0.00% | -$1.3K |
| Cid Holdco IncW EXP 06 18 203 | 444,515 | 444,515 | 0 | $4.4K | $0 | — | -$4.4K |
| Chime Financial, Inc.CL A(CHYM) | 89,878 | 0 | -89,878 | $1.84M | $0 | — | -$1.84M |
| Celcuity Inc.(CELC) | 1,249 | 0 | -1,249 | $130.7K | $0 | — | -$130.7K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 61,455 | 0 | -61,455 | $6.82M | $0 | — | -$6.82M |
| BlackSky Technology Inc.W EXP 09 09 202(BKSY) | 350,000 | 0 | -350,000 | $17.5K | $0 | — | -$17.5K |
| Murano Global Invt PlcSHS SHS | 261,875 | 0 | -261,875 | $62.9K | $0 | — | -$62.9K |
| SHF Holdings, Inc.CL A(SHFS) | 75,897 | 0 | -75,897 | $18.2K | $0 | — | -$18.2K |
| Cabaletta Bio, Inc.(CABA) | 714,710 | 0 | -714,710 | $2.22M | $0 | — | -$2.22M |
| COMPASS Pathways plcADS(CMPS) | 450,000 | 0 | -450,000 | $6.37M | $0 | — | -$6.37M |
| Context Therapeutics Inc.(CNTX) | 2,934,015 | 0 | -2,934,015 | $1.63M | $0 | — | -$1.63M |
| Evommune, Inc.(EVMN) | 180,000 | 0 | -180,000 | $2.39M | $0 | — | -$2.39M |
| EyePoint, Inc.(EYPT) | 762,594 | 0 | -762,594 | $10.91M | $0 | — | -$10.91M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 400,000 | 0 | -400,000 | $4.33M | $0 | — | -$4.33M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 182,638 | 0 | -182,638 | $6.10M | $0 | — | -$6.10M |
| Capital One Financial Corporation(COF) | 119,757 | 0 | -119,757 | $24.03M | $0 | — | -$24.03M |